Manesh Dixit, Ph.D.

Manesh Dixit, Ph.D. has comprehensive work experience in the pharmaceutical industry. Manesh served as President, CEO, and Chairman at USpharma Ltd starting in 2017. Prior to this, they held the position of President and CEO at First Time US Generics since 2013. From 2007 to 2012, they were President, COO, and Member of the Board at Nostrum Laboratories, Inc. and Nostrum Pharmaceuticals, LLC, where they successfully reversed operating losses and oversaw various departments. Dr. Dixit also founded StedixPharma, LLC in 2006 and collaborated with international generic companies on product development. As a Senior Patent Agent at Ivax Corporation from 2004 to 2006, they managed a large portfolio of projects and provided formulation strategies. Additionally, they worked as a Senior Principal Scientist and Group Leader at Andrx Pharmaceuticals, Inc from 1999 to 2004, where they developed bio-equivalent formulations for patented products and filed ANDAs. Dr. Dixit's extensive industry knowledge and leadership experience make him a valuable asset in the pharmaceutical field.

Manesh Dixit, Ph.D., completed their education in the field of pharmacy. Manesh began their academic journey in 1989 at the KMK College of Pharmacy, where they pursued a Bachelor of Pharmacy degree. Concurrently, from 1989 to 1993, they also attended the University of Bombay, where they obtained a Bachelor of Pharmacy and Diploma in Pharmacy.

Continuing their pursuit of excellence, Manesh Dixit went on to enroll at The Ohio State University from 1994 to 1998. During this time, they focused on Pharmaceutics and successfully earned their Ph.D.

Overall, Manesh Dixit's education history demonstrates their commitment to advancing their knowledge and expertise in the field of pharmacy.